CMB TECH NV (CMBT.BR) Fundamental Analysis & Valuation

EBR:CMBT • BE0003816338

Current stock price

11.08 EUR
+0.06 (+0.54%)
Last:

This CMBT.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CMBT.BR Profitability Analysis

1.1 Basic Checks

  • In the past year CMBT has reported negative net income.
  • CMBT had a positive operating cash flow in the past year.
  • CMBT had positive earnings in 4 of the past 5 years.
  • In multiple years CMBT reported negative operating cash flow during the last 5 years.
CMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFCMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

1.2 Ratios

  • With a Return On Assets value of 3.67%, CMBT perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
  • With a decent Return On Equity value of 12.04%, CMBT is doing good in the industry, outperforming 62.67% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.04%, CMBT is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA 3.67%
ROE 12.04%
ROIC 4.04%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CMBT.BR Yearly ROA, ROE, ROICCMBT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • CMBT's Profit Margin of 17.42% is amongst the best of the industry. CMBT outperforms 81.33% of its industry peers.
  • CMBT's Profit Margin has declined in the last couple of years.
  • CMBT's Operating Margin of 23.08% is fine compared to the rest of the industry. CMBT outperforms 64.00% of its industry peers.
  • In the last couple of years the Operating Margin of CMBT has declined.
  • With a decent Gross Margin value of 52.84%, CMBT is doing good in the industry, outperforming 61.33% of the companies in the same industry.
  • CMBT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 23.08%
PM (TTM) 17.42%
GM 52.84%
OM growth 3Y-1.6%
OM growth 5Y-12.14%
PM growth 3Y-25.83%
PM growth 5Y-24.32%
GM growth 3Y-1.12%
GM growth 5Y-6.04%
CMBT.BR Yearly Profit, Operating, Gross MarginsCMBT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

0

2. CMBT.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CMBT is destroying value.
  • CMBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CMBT.BR Yearly Shares OutstandingCMBT.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT.BR Yearly Total Debt VS Total AssetsCMBT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • CMBT has an Altman-Z score of 0.85. This is a bad value and indicates that CMBT is not financially healthy and even has some risk of bankruptcy.
  • CMBT has a Altman-Z score of 0.85. This is amonst the worse of the industry: CMBT underperforms 80.00% of its industry peers.
  • A Debt/Equity ratio of 1.96 is on the high side and indicates that CMBT has dependencies on debt financing.
  • The Debt to Equity ratio of CMBT (1.96) is worse than 90.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Altman-Z 0.85
ROIC/WACC0.59
WACC6.82%
CMBT.BR Yearly LT Debt VS Equity VS FCFCMBT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • A Current Ratio of 0.62 indicates that CMBT may have some problems paying its short term obligations.
  • CMBT has a Current ratio of 0.62. This is amonst the worse of the industry: CMBT underperforms 92.00% of its industry peers.
  • CMBT has a Quick Ratio of 0.62. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CMBT (0.51) is worse than 89.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.51
CMBT.BR Yearly Current Assets VS Current LiabilitesCMBT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. CMBT.BR Growth Analysis

3.1 Past

  • The earnings per share for CMBT have decreased strongly by -106.08% in the last year.
  • CMBT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.73% yearly.
  • CMBT shows a strong growth in Revenue. In the last year, the Revenue has grown by 67.96%.
  • The Revenue has been growing slightly by 6.60% on average over the past years.
EPS 1Y (TTM)-106.08%
EPS 3Y-11.23%
EPS 5Y-20.73%
EPS Q2Q%27.27%
Revenue 1Y (TTM)67.96%
Revenue growth 3Y24.92%
Revenue growth 5Y6.6%
Sales Q2Q%160.64%

3.2 Future

  • Based on estimates for the next years, CMBT will show a very strong growth in Earnings Per Share. The EPS will grow by 90.76% on average per year.
  • CMBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.67% yearly.
EPS Next Y650.86%
EPS Next 2Y144.22%
EPS Next 3Y90.76%
EPS Next 5YN/A
Revenue Next Year30.41%
Revenue Next 2Y19.87%
Revenue Next 3Y10.67%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMBT.BR Yearly Revenue VS EstimatesCMBT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CMBT.BR Yearly EPS VS EstimatesCMBT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

4

4. CMBT.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • CMBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 10.30, which indicates a very decent valuation of CMBT.
  • 84.00% of the companies in the same industry are more expensive than CMBT, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CMBT to the average of the S&P500 Index (22.10), we can say CMBT is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.3
CMBT.BR Price Earnings VS Forward Price EarningsCMBT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CMBT is valued a bit more expensive than 73.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.31
CMBT.BR Per share dataCMBT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • CMBT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CMBT's earnings are expected to grow with 90.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y144.22%
EPS Next 3Y90.76%

0

5. CMBT.BR Dividend Analysis

5.1 Amount

  • No dividends for CMBT!.
Industry RankSector Rank
Dividend Yield 0%

CMBT.BR Fundamentals: All Metrics, Ratios and Statistics

CMB TECH NV

EBR:CMBT (3/30/2026, 7:00:00 PM)

11.08

+0.06 (+0.54%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-26
Earnings (Next)05-19
Inst Owners12.76%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.50B
Revenue(TTM)2.36B
Net Income(TTM)306.64M
Analysts83.33
Price Target13.52 (22.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend4.94
Dividend Growth(5Y)116.35%
DP7.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-173.2%
Min EPS beat(2)-198.04%
Max EPS beat(2)-148.37%
EPS beat(4)0
Avg EPS beat(4)-136.26%
Min EPS beat(4)-198.04%
Max EPS beat(4)-49.61%
EPS beat(8)3
Avg EPS beat(8)39.77%
EPS beat(12)7
Avg EPS beat(12)35.97%
EPS beat(16)10
Avg EPS beat(16)32.67%
Revenue beat(2)2
Avg Revenue beat(2)34.8%
Min Revenue beat(2)22.8%
Max Revenue beat(2)46.8%
Revenue beat(4)3
Avg Revenue beat(4)17.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)46.8%
Revenue beat(8)6
Avg Revenue beat(8)22.7%
Revenue beat(12)10
Avg Revenue beat(12)33.52%
Revenue beat(16)14
Avg Revenue beat(16)39.69%
PT rev (1m)19.94%
PT rev (3m)26.28%
EPS NQ rev (1m)-10.2%
EPS NQ rev (3m)7.48%
EPS NY rev (1m)-5.59%
EPS NY rev (3m)-7.04%
Revenue NQ rev (1m)-2.1%
Revenue NQ rev (3m)1.27%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)-1.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.3
P/S 2.29
P/FCF N/A
P/OCF 12.37
P/B 1.58
P/tB 1.71
EV/EBITDA 13.31
EPS(TTM)-0.2
EYN/A
EPS(NY)1.08
Fwd EY9.71%
FCF(TTM)-2.55
FCFYN/A
OCF(TTM)0.9
OCFY8.08%
SpS4.84
BVpS7
TBVpS6.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.67%
ROE 12.04%
ROCE 5.39%
ROIC 4.04%
ROICexc 4.04%
ROICexgc 4.14%
OM 23.08%
PM (TTM) 17.42%
GM 52.84%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.6%
OM growth 5Y-12.14%
PM growth 3Y-25.83%
PM growth 5Y-24.32%
GM growth 3Y-1.12%
GM growth 5Y-6.04%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Debt/EBITDA 6.9
Cap/Depr 395.78%
Cap/Sales 71.33%
Interest Coverage 1.53
Cash Conversion 45.05%
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.51
Altman-Z 0.85
F-Score3
WACC6.82%
ROIC/WACC0.59
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.08%
EPS 3Y-11.23%
EPS 5Y-20.73%
EPS Q2Q%27.27%
EPS Next Y650.86%
EPS Next 2Y144.22%
EPS Next 3Y90.76%
EPS Next 5YN/A
Revenue 1Y (TTM)67.96%
Revenue growth 3Y24.92%
Revenue growth 5Y6.6%
Sales Q2Q%160.64%
Revenue Next Year30.41%
Revenue Next 2Y19.87%
Revenue Next 3Y10.67%
Revenue Next 5YN/A
EBIT growth 1Y-35.16%
EBIT growth 3Y22.92%
EBIT growth 5Y-6.34%
EBIT Next Year146.31%
EBIT Next 3Y31.85%
EBIT Next 5YN/A
FCF growth 1Y-499.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.43%
OCF growth 3YN/A
OCF growth 5YN/A

CMB TECH NV / CMBT.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CMB TECH NV (CMBT.BR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CMBT.BR.


Can you provide the valuation status for CMB TECH NV?

ChartMill assigns a valuation rating of 4 / 10 to CMB TECH NV (CMBT.BR). This can be considered as Fairly Valued.


How profitable is CMB TECH NV (CMBT.BR) stock?

CMB TECH NV (CMBT.BR) has a profitability rating of 4 / 10.


What is the financial health of CMB TECH NV (CMBT.BR) stock?

The financial health rating of CMB TECH NV (CMBT.BR) is 0 / 10.


How sustainable is the dividend of CMB TECH NV (CMBT.BR) stock?

The dividend rating of CMB TECH NV (CMBT.BR) is 0 / 10 and the dividend payout ratio is 7.67%.